Picture of Biosenta logo

ZRO Biosenta Income Statement

0.000.00%
ca flag iconLast trade - 00:00
Consumer DefensivesHighly SpeculativeMicro CapSucker Stock

Annual income statement for Biosenta, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.

2019
September 30th
2020
September 30th
2021
September 30th
2022
September 30th
2023
September 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue00.0020.1680.0010.001
Cost of Revenue
Gross Profit000.0990.0010
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Operating Interest Expense / Income
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses0.530.7632.211.466.3
Operating Profit-0.53-0.762-2.04-1.46-6.3
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-0.53-0.762-2.04-1.46-6.3
Provision for Income Taxes
Net Income After Taxes-0.53-0.762-2.04-1.46-6.3
Net Income Before Extraordinary Items
Net Income-0.53-0.762-2.04-1.46-6.3
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-0.53-0.762-2.04-1.46-6.3
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.038-0.048-0.114-0.067-0.058